ANVISA registration 80134860304Valid until Dec 11, 2033ANTI-HUMAN GLOBULIN (COOMBS)
ANVISA Registration Number: 80134860304GRIFOLS BRASIL LTDADIAGNOSTIC GRIFOLS, S.A.Risk Class III
Device names
- Technical name
- ANTI-HUMAN GLOBULIN (COOMBS)
- Risk class
- Class III
PT: GLOBULINA ANTI-HUMANA (COOMBS)
Registration details
- Registration Number
- 80134860304
- Process Number
- 25351209198202331
- CNPJ
- 02513899000171
Company information
- Registration Holder
- GRIFOLS BRASIL LTDA
- Manufacturer
- DIAGNOSTIC GRIFOLS, S.A.
- Manufacturing Country
- Spain
PT: ESPANHA
Dates and status
- Publication Date
- Dec 11, 2023
- Validity
- 11/12/2033
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for ANTI-HUMAN GLOBULIN (COOMBS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80134860304 and manufactured by DIAGNOSTIC GRIFOLS, S.A.. The registration is held by GRIFOLS BRASIL LTDA with validity until Dec 11, 2033.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.